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ABSTRACT
The TET family of FE(II) and 2-oxoglutarate-
dependent enzymes (Tet1/2/3) promote DNA
demethylation by converting 5-methylcytosine
to 5-hydroxymethylcytosine (5hmC), which they
further oxidize into 5-formylcytosine and 5-
carboxylcytosine. Tet1 is robustly expressed in
mouse embryonic stem cells (mESCs) and has
been implicated in mESC maintenance. Here we
demonstrate that, unlike genetic deletion, RNAi-
mediated depletion of Tet1 in mESCs led to a sig-
nificant reduction in 5hmC and loss of mESC
identity. The differentiation phenotype due to Tet1
depletion positively correlated with the extent of
5hmC loss. Meta-analyses of genomic data sets
suggested interaction between Tet1 and leukemia
inhibitory factor (LIF) signaling. LIF signaling is
known to promote self-renewal and pluripotency in
mESCs partly by opposing MAPK/ERK-mediated
differentiation. Withdrawal of LIF leads to differenti-
ation of mESCs. We discovered that Tet1 depletion
impaired LIF-dependent Stat3-mediated gene acti-
vation by affecting Stat3’s ability to bind to its
target sites on chromatin. Nanog overexpression
or inhibition of MAPK/ERK signaling, both known
to maintain mESCs in the absence of LIF, rescued
Tet1 depletion, further supporting the dependence
of LIF/Stat3 signaling on Tet1. These data support
the conclusion that analysis of mESCs in the hours/
days immediately following efficient Tet1 depletion
reveals Tet1’s normal physiological role in maintain-
ing the pluripotent state that may be subject to
homeostatic compensation in genetic models.
INTRODUCTION
Embryonic stem cells (ESCs) appear to have an unique
epigenetic state that maintains the pluripotent genome in
a stable program of self-renewal, while allowing rapid
induction of alternate transcriptional programs to
initiate differentiation (1–8). DNA methylation is one of
the principle regulators of the epigenetic landscape that
shapes and reﬁnes gene expression programs during
embryogenesis and stem cell differentiation. While mech-
anisms of establishment and maintenance of DNA methy-
lation by DNA methyltransferases are well characterized
(9,10), it was less clear which enzymatic machinery is
responsible for DNA demethylation or even which
pathways lead to DNA demethylation (11,12). Recently,
it was discovered that proteins of the Tet family of FE(II)
and 2-oxoglutarate-dependent enzymes (Tet1/2/3) oxidize
5-methylcytosine (5mC) to 5-hydroxymethylcytosine
(5hmC) (13–17), which they further oxidize into 5-formyl
cytosine and 5-carboxylcytosine, thereby promoting DNA
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shown to have roles in cancer and stem cell biology
(13,16,24,25). Mouse embryonic stem cells (mESCs) deﬁ-
cient in DNA methyltransferases Dnmt1, Dnmt3a and
Dnmt3b lack 5mC as well as 5hmC implying that 5hmC
marks are probably derived from pre-existing 5mC marks
(26,27).
In mESCs, Tet1 is expressed at high levels, comparable
to those of the master pluripotency factor Oct4 (16,28).
Tet2, though well expressed in mESCs, is 5-fold less
abundant than Tet1 (28). Tet3 is variably expressed in
many tissues but not in mESCs (16). Though various
tissues express one or more Tet proteins, the 5hmC modi-
ﬁcation is particularly abundant in mESCs and Purkinje
neurons (13,14,16,29). In mESCs, Tet1 binding and 5hmC
occupancy are correlated with CpG density, are enriched
at the promoters and gene bodies of nearly two-thirds of
all genes, and have been linked to both gene activation
and repression (27,30–33). Tet1 has also been shown to
be required for the recruitment of transcriptional repres-
sors Ezh2 (30) and Sin3a (27) at CpG-rich promoters of
developmental regulators. Though Tet1-mediated regula-
tion is believed to be due to its catalytic activity, Tet1
might have other functions in addition to converting
5mC to 5hmC (27).
A recent study reported that RNAi-mediated knock-
down (KD) of Tet1 in mESCs resulted in downregulation
of pluripotency marker Nanog and loss of undifferentiated
state implicating Tet1 in mESC maintenance (16). In
contrast, subsequent studies found that Tet1 KD cells
were morphologically indistinguishable from control
mESCs with no changes in Nanog expression, modest re-
duction in total 5hmC levels, and a minor-to-moderate
increase in 5mC levels (26–28,31). Discrepancy between
these studies may be due to differences in KD efﬁciency,
off-target effects, or homeostatic compensation masked by
antibiotic selection. More recently, it was reported that
Tet1
 /  mice are viable, fertile and grossly normal, and
that Tet1
 /  mESCs maintained a normal undifferenti-
ated mESC morphology with only  35% reduction in
total 5hmC levels (34). Since only a modest reduction in
5hmC levels is observed in this genetic model, it is possible
that maternal contribution or unaltered Tet2 in Tet1 null
cells may be compensating Tet1’s function, thereby
obscuring the direct impact of Tet1 loss. The discrepancies
observed in the various RNAi-mediated depletion experi-
ments in addition to the puzzling retention of 5hmC in the
Tet1 null mESCs suggest that unanswered questions
remain regarding the role of Tet1 in the maintenance of
the pluripotent state of mESCs.
To understand and clarify the role of Tet1 and 5hmC in
epigenetic and transcriptional regulation of mESCs, we
used RNAi to acutely deplete Tet1 in mESCs and per-
formed expression and genome-wide 5hmC occupancy
studies. We ﬁnd that acute short-term depletion as
opposed to genetic deletion of Tet1 results in a signiﬁcant
decrease in 5hmC levels, downregulation of pluripotency-
associated factors, impairment of LIF-dependent Stat3-
mediated gene activation, and loss of embryonic stem
cell identity.
MATERIALS AND METHODS
Mouse ES cell culture, RNAi and alkaline
phosphatase staining
Oct4GiP mESCs were kindly provided by Dr Austin
Smith. E14Tg2a mESCs were obtained from Mutant
Mouse Research Resource Centers, and J1 mESCs were
obtained from ATCC. The cells were routinely maintained
on gelatin-coated plates in the ESGRO complete plus
clonal grade medium (Millipore), and were used at
passage 20–35 for experiments. For siRNA transfections,
mESCs were cultured on gelatin-coated plates in
M15 medium: Dulbecco’s Modiﬁed Eagle Medium
(Invitrogen) supplemented with 15% Fetal Bovine Serum
(FBS) (Invitrogen), 10mM 2-mercaptoethanol, 0.1mM
non-essential amino acids (Invitrogen), 1  EmbryoMax
nucleosides (Millipore), 1000 U of ESGRO (Millipore).
For cells to be harvested or stained 96h after transfection,
20–25 10
3 mESCs were transfected with siRNAs at
100nM in M15 medium in one well of a 96-well plate.
About 0.7ml of Lipofectamine 2000 (Invitrogen) was
pre-mixed with 10ml of Opti-MEM (Invitrogen) and then
mixed with 1 10
 11mol siRNAs. Dissociated mESCs
were plated at 25 10
3 per well in 100ml of M15 medium
in gelatin-coated plates. siRNA–lipids complexes were
incubated at room temperature for 15–30min and then
added to the cells. About 25–50% of the cells in each
well was re-plated into one well of a 12-well plate the
next day, and cultured in M15 medium for another 3
days. For cells to be harvested 48h after transfection,
75 10
3 mESCs were transfected with siRNAs at 50nM
in M15 medium in one well of a 24-well plate, and cells
were collected 2 days after transfection. RNAi experiments
were performed using indicated individual siRNAs: Tet1
siRNA #1 (Invitrogen, MSS284895), Tet1 siRNA #2
(Invitrogen, MSS284897), Tet1 siRNA #3 (Dharmacon,
D-062861-01), Tet1 siRNA #4 (Dharmacon,
D-062861-02), Tet1 siRNA #5 (Dharmacon, D-062861-
03), Tet1 siRNA #6 (Dharmacon, D-062861-04) and
control siRNA duplex targeting ﬁreﬂy luciferase
(Dharmacon, 50-CGTACGCGGAATACTTCGA). For
lineage marker [quantitative reverse-transcriptase PCR
(qRT-PCR)] and microarray analysis, cells were harvested
48 and 96h after transfection for RNA extraction. For
alkaline phosphatase (AP) staining, cells were ﬁxed,
permeablized and stained for AP activity with the
Alkaline Phosphatase Detection Kit (Millipore).
Nanog overexpression cells
Mouse Nanog was cloned into pcDNA-EF-HA/Flag
vector and sequence veriﬁed (see Supplementary
Material). The resulting plasmid, mNanog-pcDNA-
EF-HA/Flag, was transfected into Oct4GiP cells with
Lipofectamine 2000 (Invitrogen), and the cells were
selected with G418 and plated at colonal density. Single
clones were picked and expanded, and clone #2 was
chosen for the experiment. The expression of the exogen-
ous HA/Flag-tagged Nanog was estimated to be at
the same level of the endogenous Nanog based on
western blot.
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Oct4GiP cells were transfected in 96-well plates: 0.35mlo f
Lipofectamine 2000 (Invitrogen) was pre-mixed with 10ml
of Opti-MEM (Invitrogen) and then mixed with
5 10
 12mol siRNAs. Dissociated cells were plated
at 10 10
3 per well in 100ml of M15 medium in
gelatin-coated plates. siRNA–lipid complexes were
incubated at room temperature for 15–30min and then
added to the cells. Cells were cultured in M15 medium
with daily medium change. Four days after transfection,
cells were lifted and dissociated by trypsinization, pipetted
into single cell suspension in 10% FBS in Phosphate
Buffered Saline (PBS), and ﬂuorescence-activated cell
sorting (FACS) analyzed on LSRII FACS analyzer
(BD). Percentage of differentiation was determined by
measuring the percentage of green ﬂuorescent protein
(GFP)-negative cells. For each experimental condition,
3–4 independent transfections were carried out, and data
was plotted as mean±SEM (standard error of the mean).
Western blot
Cells were directly lysed in SDS–PAGE sample buffer.
Proteins were resolved by SDS–PAGE, transferred to
nitrocellulose membrane using iBlot (Invitrogen), and
probed with the indicated antibodies. Loading was
normalized based on Ran or Tubulin. Primary antibodies
used: Nanog (Millipore, AB9220), Stat3–Y705-phospho-
speciﬁc (Cell Signaling, 9145), Stat3 (Cell Signaling, 9132),
Dnmt3a (Santa Cruz, H-295), Dnmt3b (IMEGENEX,
IMG-184A), Ran (BD, 610340) and Tubulin (Santa
Cruz, sc-9104).
Quantitative RT-PCR
Total RNAs were prepared from cells using the RNeasy
(Qiagen), and cDNAs were generated using the
Omniscript RT kit (Qiagen) according to the manufactur-
er’s instructions. Quantitative PCRs were performed using
the Ssofast Evagreen Supermix (Bio-Rad) on the Bio-Rad
CFX-384 or CFX-96 Real-Time PCR System. At least
three biological repeats were carried out for each experi-
ment. For every biological repeat, triplicate or quadrupli-
cate PCR reactions were performed for each sample, and
Actin was used for normalization. Data was plotted as
mean±SEM. Please refer to Supplementary Table S1
for gene speciﬁc primers used for RT-PCR analysis.
5hmC slot blot, and genome-wide mapping and
analysis of 5hmC
Mouse E14Tg2a cells were transfected with control
siRNA or an siRNA targeting Tet1 in 6-well plates.
Cells were lysed 96h after transfection in Trizol reagent,
and both total RNA and genomic DNA were prepared
according to manufacturer’s instructions. Total RNA
was used to determine the Tet1 KD efﬁciency. Genomic
DNA was quantiﬁed with NanoDrop, and 100 or 500ng
was loaded on GE Hybond
+ nylon membrane using the
GE slot blot device according to manufacturer’s instruc-
tions and blotted for 5hmC. Primary antibody used:
5hmC (Active Motif, 39769). Relative signal strengths of
5hmC bands were quantiﬁed using the Image-J software
(http://imagej.nih.gov/ij/).
For genome-wide mapping of 5hmC, the genomic DNA
obtained from control KD and Tet1 KD cells were
processed using the QUEST 5hmC detection kit (Zymo
Research) according to manufacturer’s instructions.
Brieﬂy, the genomic DNA was treated with 5hmC
glucosyltransferase enzyme, which speciﬁcally tags the
5hmC in DNA with a glucose moiety yielding a
modiﬁed base, glucosyl-5hmC. Next the DNA was
digested using glucosyl-5hmC sensitive restriction endo-
nuclease MspI. MspI efﬁciently cleaves the DNA when
cytosine, 5mC, or 5hmC but not glucysyl-5hmC is
located at the inner C position within its recognition
sequence (i.e. CCGG). In other words, the 5hmC sites in
genomic DNA treated with 5-glycosyltransferase enzyme
are protected from MspI digestion. By comparing the
qPCR or next-generation sequencing results for treated
versus untreated genomic DNA, 5hmC sites are
detected (see below for details). Computational analysis
indicate that digesting mouse genomic DNA with
MspI, selecting 40–220bp fragments, and performing
36-bp sequencing would cover  1 million distinct CpG
dinucleotides ( 5% of all CpGs), with roughly half
located within ‘CpG islands’ (including sequences from
90% of all CpG islands) and the rest distributed
between other relatively CpG-poor sequence features
(35). Every MspI cleaved sequence read will thus include
at least one informative CpG position. Based on this in-
formation, MspI-digested DNA from treated and untreat-
ed samples derived from control and Tet1 KD mESCs
were size-selected (40–220bp) and sequenced using
Illumina GAII.
Sequenced 36-bp reads were aligned to the reference
genome (mouse NCBI36/mm8 assembly) using Bowtie
0.12.2 (36). Those reads that mapped to unique genomic
locations with at most two mismatches were retained.
Roughly  50–65% of all reads were mapped to unique
genomic locations. To increase the mapping efﬁciency, we
trimmed one base from the 30-end of the unmapped reads,
aligned the residual 36-bp reads to the reference genome
and retained those that mapped to unique genomic loca-
tions. This procedure was repeated until the residual reads
were of length 18, and, in each iteration, reads that
mapped to unique genomic locations were retained for
further analysis. The reads that mapped to unique
genomic locations but whose corresponding 50-t o
30-sequence in the reference genome neither started with
CGG nor ended with GGC were considered noise and
discarded. The rationale for this is because the MspI
cleaves the DNA containing its recognition site CCGG
at the inner C position (C/CGG) (37), the DNA fragments
that is sequenced must all start with CGG or end with
GGC (complementary strand). Reads that start or end
with anything other than CGG or GGC, respectively,
are likely to be byproducts of DNA degradation or
sequencing errors. The resulting mapped reads for the
four samples (control KD treated, control KD untreated,
Tet1 KD treated and Tet1 KD untreated) were normalized
by total reads in each sample so that the number of reads
mapping to a speciﬁc site is directly comparable across all
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samples were excluded from the analysis. A site was
deﬁned as a 5hmC site only if the normalized read count
at this site in the control untreated sample is at least
1.5-fold higher than that in the control treated sample.
A 5hmC site was deﬁned to have reduced 5hmC levels in
Tet1 KD mESCs only if
5hmC ¼
Nuntreated
controlKD=Ntreated
controlKD
Nuntreated
Tet1KD =Ntreated
Tet1KD
  1:5
where 5hmC measures the reduction in 5hmC levels in
Tet1 KD cells and Nt
s is the normalized read count in
sample s with treatment t. Genes were considered to
have 5hmC occupancy if they have one or more detected
5hmC sites within 5kb upstream of the transcription start
site (TSS) to the transcription end site (TES). Please refer
to Supplementary Table S2 for PCR primers used for
quantitative 5hmC analysis.
Chromatin immunoprecipitation
E14Tg2a mESCs were crosslinked with 1% formaldehyde
in PBS for 10min, and the resulting chromatin was
sonicated using Diagenode Bioruptor for 15–18 cycles,
30s per cycle with a 30s rest between each cycle, to
obtain  200–500bp fragments. Chromatin immunopre-
cipitation (ChIP) was performed by incubating indicated
antibodies with Dynabeads protein A magnetic beads
(Invitrogen, 100-02D) for 4–6h at 4 C, followed by over-
night incubation with the chromatin at 4 C. Subsequent
washing and reverse crosslinking steps were performed as
described earlier (38). Each ChIP was performed using
chromatin from  2 10
7cells. Primary antibodies used:
Stat3 (Santa Cruz, C-20), H3K9me3 (Abcam, ab8898)
and IgG (Santa Cruz, H-270). Please refer to
Supplementary Table S3 for ChIP primers used to
analyze Stat3-target/binding sites.
ChIP-Seq factor binding data analysis
Published ChIP-Seq data sets for various transcription fac-
tors and chromatin remodelers (listed in Supplementary
Table S4) were downloaded from the Gene Expression
Omnibus (GEO) (http://www.ncbi.nlm.nih.gov/geo/) or
the BROAD Institute website. In cases where the data
was mapped to mouse reference genome assembly mm9,
the data was realigned to mm8 assembly using the liftOver
tool (39). Where available for download, binding sites
(peaks) as deﬁned in the original publication were used.
Otherwise SISSRs (40) was used for peak calling. Direct
target genes of a particular factor (for example, Tet1) were
deﬁned as genes that have one or more detected factor
binding sites within 5-kb upstream of the TSS to the TES.
Microarray gene expression data analysis
Raw CEL ﬁles (Affymetrix array type Mouse 430
2.0) generated from this study were processed using
relevant R/Bioconductor packages (41). Speciﬁcally,
RMA (42) was used for background correction and data
normalization. Probe sets were deﬁned using Entrez gene
based custom chip deﬁnition ﬁles (CDFs), version 13
(http://brainarray.mbni.med.umich.edu/Brainarray/Data
base/CustomCDF/genomic_curated_CDF.asp) (43). This
resulted in a single expression intensity measure per Entrez
gene ID. All subsequent analyses were carried out on the
log2 scale. To determine differentially expressed genes, a
family-wise moderated t-test (44) (KD versus control) was
performed followed by a multiple testing correction pro-
cedure to control the false discovery rate (FDR) (45).
Unless otherwise noted, genes were considered differen-
tially expressed if their FDR 0.1 and fold change  1.5.
Since global gene expression changes due to Tet1 KDs
using Tet1 siRNAs #1 and #2 were highly similar, we
treated them as biological replicates in the differential ex-
pression analysis. Unsupervised hierarchical clustering
was performed using the CLEAN software package (46).
Functional enrichment analysis of differentially regulated
lists of genes was performed using R packages CLEAN
(46) and GO.db (41).
Published microarray data sets (listed in Supplementary
Table S5) were downloaded from GEO (http://www.ncbi
.nlm.nih.gov/geo/). Where available, raw CEL ﬁles were
re-processed using the above described microarray pro-
cessing pipeline. Otherwise, the respective Series Matrix
File was used to obtain preprocessed expression values
and corresponding probe annotations. All data were
transformed and analyzed on the log2 scale. Each probe
identiﬁer was mapped to an Entrez gene ID using relevant
Bioconductor packages by continually matching annota-
tions in the following order until an Entrez gene ID was
found: Entrez gene ID, RefSeq ID, gene symbol or alias,
gene name, unigene ID, Ensembl transcript ID. Probes
mapping to the same Entrez gene ID were averaged
(after the log-transformation). Fold changes and
adjusted P-values (KD versus control) using moderated
t-statistic described above were then computed for each
data set independently.
Data availability
All microarray and 5hmC sequencing data generated for
this study were deposited in NCBI GEO repository under
the accession number GSE34267.
RESULTS
Acute depletion of Tet1 results in loss of embryonic
stem cell identity
To elucidate the role of Tet1 and 5hmC in epigenetic and
transcriptional regulation of mESC self-renewal and
pluripotency, we used RNAi to acutely deplete Tet1 in
Oct4GiP mESCs, which express the GFP under the
control of the Oct4 promoter (47). Since Oct4 is exclusive-
ly expressed in ESCs, the GFP expression faithfully cor-
relates with the ESC identity. Two small-interfering RNAs
(siRNAs #1 and #2) targeting Tet1 were used to ensure
that the effects were speciﬁc. Cells transfected with
siRNAs were maintained in normal mESC culture condi-
tions for 4 days, and subjected to FACS to determine the
fraction of differentiated (GFP-negative) cells. Acute de-
pletion of Tet1 resulted in small but signiﬁcant increase in
the percentage of differentiated cells (Figure 1A).
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qRT-PCR and western blot (Figure 1B and
Supplementary Figure S1A). Examination of Tet1 KD
mESCs for colony morphology and AP staining revealed
morphological changes and loss of AP staining consistent
with differentiation (Figure 1C). The outcome remained
similar even when E14Tg2a or J1 cell lines were used
(Supplementary Figure S1B). To rule out the possibility
that the observed changes were due to siRNA off-target
effects, we used four additional siRNAs (#3–6), some
of which were used in other studies that observed
no obvious phenotype (28,31), and conﬁrmed that acute
depletion of Tet1 indeed induces morphological changes
and loss of AP staining consistent with differentiation
(Supplementary Figure S1B).
ESC markers are downregulated and differentiation
markers are upregulated upon Tet1 depletion
To determine whether Tet1 depletion has an effect on gene
expression programs inﬂuencing mESC self-renewal,
pluripotency and differentiation, we used microarrays to
proﬁle global gene expression in mESCs transfected with
control and Tet1 siRNAs at 96h after transfection.
Pluripotency-associated genes such as Nanog, Esrrb,
Tcl1, Tbx3, Klf2, Klf4, Lefty1, Lefty2, Tcfcp2l1 and
Prdm14 were downregulated, and differentiation-
associated genes including ectoderm and neuronal
markers Fgf5, Pitx2, Nestin, Nefm, CD133 (Prom1),
CD44, Lef1 and Zic1 and trophectoderm markers Eomes
and Krt8/18/19 were upregulated in response to Tet1 KD
(Figure 1D). Gene ontology analysis of transcripts
downregulated at 96h revealed enrichment of many
terms related to stem cell maintenance and proliferation,
whereas upregulated transcripts were enriched for terms
related to development and differentiation (Figure 1E). To
understand the kinetics of downstream effects of Tet1 KD,
we also carried out microarray analysis at 48h after
siRNA transfection when Tet1-depleted cells (Figure 1B
and Supplementary Figure S1A) were morphologically in-
distinguishable from control cells (Supplementary Figure
S1D). Interestingly, our 48h Tet1 KD data clustered
tightly with those from shRNA-mediated Tet1 KD
studies that did not observe morphological changes even
past 96h (Figure 1D and Supplementary Figure S1C), and
away from our 96h Tet1 KD data that accompanies mor-
phological changes, suggesting a kinetic effect. The lack of
phenotype in shRNA-mediated depletion studies could be
due to the (i) differences in reaction rates in shRNA-
versus siRNA-mediated knockdowns as a result of add-
itional processing time necessary for the shRNA hairpin
structure to be cleaved into siRNA or (ii) homeostatic
compensation of Tet1’s function masked by antibiotic
selection.
We performed qRT-PCR and conﬁrmed gene expres-
sion changes observed in the microarray analysis. Tet1
depletion decreased the expression of key pluripotency
factors: Nanog by nearly 3-fold, and Oct4 and Sox2 by
small, but reproducible and statistically signiﬁcant,
 1.25-fold. Other pluripotency-associated genes such as
Klf4, Esrrb, Tcl1, Tbx3, Prdm14 and Nodal antagonists
Lefty1 and Lefty2, which are among the earliest to be
downregulated upon ESC differentiation (48), were
downregulated by  2- to 4-fold (Figure 1F). Tet1 deple-
tion also increased the expression of several differentiation
genes including Pitx2, Nestin, Nefm, Lef1 and Zic1 that
are largely associated with Ectoderm lineage (Figure 1F).
Furthermore, these changes were consistent across
Oct4GiP, E14Tg2a and J1 mESCs (Supplementary
Figure S2A), and remained consistent even when using
an siRNA that was used in two previous studies that
observed no obvious phenotype (28,31) (Supplementary
Figure S2B). Taken together, we concluded that acute
RNAi-mediated depletion of Tet1 results in the loss of
mESC identity.
Tet1 depletion results in signiﬁcant reduction in total
5hmC levels
Examination of total 5hmC levels in Tet1-depleted mESCs
using slot blot revealed a signiﬁcant reduction in 5hmC
compared to cells transfected with control siRNA
(Supplementary Figure S2C). The severity of observed
morphological changes positively correlated with the
extent of 5hmC loss (Figure 1G). We suspected that the
downregulation of Tet2 in Tet1-depleted cells (Figure 1D),
also observed in one other report with ﬁndings consistent
with ours (30), might also be a contributor to reduced
5hmC levels. Quantitative RT-PCR analysis of Tet2 in
Tet1-depleted mESCs revealed a reproducible and statis-
tically signiﬁcant  1.5-fold reduction in Tet2 levels
(Supplementary Figure S2D). This along with Tet1 occu-
pancy at Tet2 promoter (Supplementary Figure S2E) sug-
gested regulation of Tet2 by Tet1. Together, these data
revealed that the acute reduction in 5hmC primarily due
to Tet1 KD and also possibly due to indirect reduction in
Tet2 levels is probably the cause for the loss of mESC
identity.
Tet1-mediated gene regulation is context dependent
To investigate the role of Tet1 and 5hmC in the mainten-
ance of mESC identity on the molecular level, we examined
the genes that were differentially expressed upon Tet1 de-
pletion in our microarray analysis. Using a reasonably
stringent criterion (FDR<0.1; fold  1.5), we identiﬁed
530 upregulated and 389 downregulated genes
(Supplementary Table S7). Examination of published
Tet1 occupancy data (27,30) revealed that Tet1 binds to
72% of upregulated and 63% of downregulated genes with
nostatistically signiﬁcant preference forone group over the
other, which is similar to the pattern observed with other
factors known to play diverse regulatory roles in gene regu-
lation such as the insulator binding transcription factor
CTCF (Figure 2A and Supplementary Figure S3A). No
correlation between Tet1 binding and gene expression
changes was observed even when analyzing all genes with
expression above detectable levels (Supplementary Figure
S3B). These data indicate that Tet1 binding alone is not
predictive of Tet1’s function as an activator or a repressor.
Tet1 has been reported to be required for the recruit-
ment of transcriptional repressors Ezh2 (30) and Sin3a
(27) at CpG-rich promoters of developmental regulators.
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Figure 1. Depletion of Tet1 and 5hmC levels results in loss of mouse embryonic stem identity. (A) Oct4GiP mESCs were transfected with indicated
siRNAs in normal ESC medium and cultured for 96h. The percentage of differentiated cells was determined by measuring the percentage of
GFP-negative cells using FACS at 96h after transfection (**P<0.001; *P<0.01). Error bars represent SEM of three experiments. (B) Relative
Tet1 mRNA level in control and Tet1 KD Oct4GiP mESCs 48h after transfection. Data are normalized to Actin. Error bars represent SEM of three
experiments (**P<0.001). Error bars represent SEM of three experiments. (C) AP staining of Oct4GiP mESCs transfected with control
siRNA, and Tet1 siRNAs #1 and #2. Cells were cultured in normal ESC medium, and AP staining was performed 96h after transfection.
Nucleic Acids Research,2012, Vol.40, No. 8 3369
(continued)We ﬁnd that genes upregulated upon Tet1 KD are
enriched for binding of polycomb members Suz12, Ezh2
and Ring1b (Figure 2A and Supplementary Figure S3A),
whereas downregulated genes are enriched for binding
of Stat3, Klf4, Oct4, Esrrb and Sin3a among others
(Figure 2A). Since Tet1 binds to nearly two-thirds of all
genes, its co-occupancy with other transcription factors is
rather high, which could be misinterpreted for its func-
tional interaction with these factors. When normalized
by expected frequencies, Tet1’s co-occupancy with
other factors appears insigniﬁcant compared to that
between factors that are known to function together
(Supplementary Figure S3C). Like esBAF, a mESC
speciﬁc chromatin remodeling complex (49) that facilitates
both activation and repression (50,51), we propose that
Tet1 probably plays a similar role as a general facilita-
tor/recruiter of activating and repressing factors in a
context dependent manner.
Tet1 depletion results in genome-wide reduction in
5hmC levels
To determine the extent of 5hmC loss in Tet1 KD cells on
a genomic scale, we used a modiﬁed version of methyla-
tion sensitive restriction enzyme sequencing (52) and
generated nucleotide resolution 5hmC maps covering
 90% of sequences located within CpGs islands in
control and Tet1 KD mESCs (see ‘Materials and
Methods’ section for details). We identiﬁed 57895 5hmC
sites in control mESCs, of which 32652 had at least
1.5-fold reduction in 5hmC levels in Tet1 KD cells
(Supplementary Table S8). Quantitative PCR was per-
formed to validate 5hmC sites and reduction in 5hmC
levels (Supplementary Figure S3D). We ﬁnd that genes
that were upregulated or downregulated upon Tet1 deple-
tion are equally likely to contain 5hmC sites and experi-
ence reduced 5hmC levels (Figure 2B), which is consistent
with the established dual roles of Tet1 and 5hmC in
both gene activation and repression (27,30,33). These
data indicate that an acute depletion of Tet1 causes sig-
niﬁcant global reduction in 5hmC levels that were not
speciﬁc to gene classes, and that the directionality of
gene expression change (up/down) is probably determined
by the gene context and local transcription factor occu-
pancy (Figure 2A).
Meta-analysis of genomic data suggests interaction
between Tet1 and LIF/Stat3 signaling
We next examined the fate of Tet1 regulated genes upon
KD or knockout of other pluripotency factors. A
meta-analysis of microarray data from published studies
revealed that genes that are differentially expressed upon
Tet1 KD underwent similar expression changes upon
leukemia inhibitory factor (LIF) withdrawal or after de-
pletion of key pluripotency-associated factors such as
Esrrb, Tcl1, Tbx3 and Klf2/4/5, known to be associated
with LIF/Stat3 signaling (8,53–55) (Figure 2C), suggesting
Tet1’s possible interaction with or co-regulation of tran-
scriptional circuit regulated by LIF/Stat3 signaling
(Figure 2A). In contrast, Tet1-regulated genes underwent
largely divergent changes upon deletion/depletion of tran-
scriptional repressors Tcf3 and Sall4 (Figure 2C).
LIF-dependent Stat3-mediated gene activation is
dependent on Tet1
To examine Tet1’s possible mechanistic interaction with
LIF/Stat3 signaling (Figure 2A and C), we analyzed
global gene expression changes upon Tet1 depletion
against those after LIF withdrawal. Tet1-depleted and
LIF-starved mESCs undergo similar changes in the
global transcriptional proﬁle (Figure 3A). The set of
genes co-activated by Tet1 and LIF includes a number of
factors essential for pluripotency, including Esrrb, Tcl1
and Tbx3 (56,57). This suggested that Tet1 or Tet1-
dependent 5hmC levels might be required for LIF-
dependent Stat3-mediated gene activation. To further
explore this connection, we decided to study Tet1 KD
mESCs 48h after transfection, when Tet1 is depleted but
the cells appeared normal compared to control transfected
cells (Figure 1B, Supplementary Figure S1A and D). This
time point was chosen so that we could clearly distinguish
cause from effect. First, we asked whether LIF/Stat3 signal
transduction was impaired in Tet1 KD mESCs. No signiﬁ-
cant changes in mRNA levels for Stat3 or LIF chimeric
receptor consisting of gp130 and LIF receptor (LIFR)
were observed at 48h (Figure 3B and C). Tet1-depleted
mESCs at 48h after transfection had no signiﬁcant
changes in total Stat3 or Nanog levels but a modest reduc-
tion in phosphorylated/activated Stat3 (Figure 3D).
Next, we examined the ability of Stat3 to bind to its target
sites on chromatin in the absence of Tet1. ChIP experiment
Figure 1. Continued
See Supplementary Figure S1B for AP staining results for siRNA #1 and four additional siRNAs on Oct4GiP, J1 and E14tg2a mESCs.
(D) Expression fold changes of selected genes upon Tet1 KD in mESCs based on microarray analysis performed 48 and 96h after transfection.
Fold changes from data generated for this study [Tet1-KD (96h) #1, #2 and Tet1-KD (48h) #1] are presented alongside fold changes observed in
recently published Tet1 KD ( 96h) or knockout studies (color-coded on the top-right). Each column corresponds to fold changes obtained from an
individual array computed in relation to its corresponding control array. Observed/reported morphological changes are symbolically indicated at the
top, with columns ordered based on unsupervised hierarchical clustering. See Supplementary Figure S1C for a comprehensive heatmap. (E) Gene
ontology analyses of up- and down-regulated genes in Tet1 KD cells compared to control cells. Only selected categories are shown. For complete
lists, see Supplementary Table S6. (F) Relative mRNA levels of selected mESC pluripotency-associated genes and lineage marker genes in control and
Tet1 KD mESCs at 96h after transfection. The mRNA levels in control cells are set as one. Data are normalized to Actin. Error bars represent SEM
of three experiments. (G) Scatter plot showing strong positive correlation among relative Tet1 mRNA levels, relative total 5hmC levels, morphogical
changes, and AP staining in control and Tet1 KD E14Tg2a mESCs. Each data point corresponds to a siRNA that was used for transfection. The
y-axis indicates relative Tet1 mRNA levels 96h after KD, and the x-axis represents quantiﬁed intensity of 5hmC signal inferred from slot blot (96h).
Bottom panel show the corresponding representative morphological changes and AP staining for each siRNA. Error bars represent SEM of data
from ﬁve replicates (different amounts of DNA were spotted) from two independent experiments.
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Stat3 binding was affected at many gene targets co-bound
and co-activated by Tet1 and Stat3 (Figure 3E) indicating
that Tet1 is required to facilitate LIF/Stat3 responsiveness
in mESCs by enabling Stat3 to bind to its target sites on
chromatin. Since the expression changes due to loss of Stat3
binding at Stat3-activated genes is not evident at 48h but
only at 96 after Tet1 KD (Figure 3E), we concluded that the
loss of Stat3 binding precedes loss of expression. We do not
rule out the possibility that a modest reduction in
phosphorylated Stat3 levels (Figure 3D) might also have
played a role in impaired Stat3 binding. Regardless, the
LIF-dependent Stat3-mediated gene activation in mESCs
is dependent on Tet1.
Nanog overexpression or inhibition of MAPK/ERK
signaling rescues Tet1 KD phenotype
Since mESCs can be propagated without activation of
Stat3 by imposing constitutive expression of core
pluripotency factor Nanog (58), we checked if
Nanog overexpression (Figure 4A) could rescue the differ-
entiation phenotype exhibited by Tet1 KD cells. As
expected, exogenous Nanog largely rescued the morpho-
logical changes and AP activity in Tet1 KD cells
(Figure 4B). Also, since mESCs can be propagated
without Stat3 activation by suppressing prodifferentiative
MAPK/ERK signaling (59), we tested if mESCs trans-
fected with Tet1 siRNA in 2i medium (which inhibits
MAPK/ERK and Gsk-3b signaling) blocks differenti-
ation. We found that while Tet1 depletion slightly
decreased cell viability in 2i medium (data not shown),
the expression of pluripotency-associated factors Nanog,
Tcl1, Klf4 and Lefty2 were largely rescued (Figure 4C). In
addition, Tet1 KD in 2i medium also suppressed
upregulation of differentiation genes such as Pitx2,
CD133, Nefm and Lef1. Together, these data provide
evidence to further support the dependence of LIF/Stat3
signaling on Tet1.
AB C
Figure 2. Meta-analysis of genomic data sets suggests interaction between Tet1 and LIF/Stat3 signaling. (A) Top: Transcription factor occupancy at
919 genes differentially expressed upon Tet1 KD (389 downregulated and 530 upregulated). Genes are represented along the y-axis and factor
occupancy is denoted by blue bar. Target gene occupancy is deﬁned as factor occupancy within 5-Kb upstream of the gene’s TSS and/or within its
gene body. Bottom: Log-fold enrichment of factor occupancy at up/downregulated genes. Red and green histograms denote enrichment in up- and
down-regulated genes, respectively. *P<0.01 after Bonferroni adjustment for multiple testing. (B) Top: Presence/absence of 5hmC sites (5hmC) in
control mESCs, and 5hmC sites with  1.5-fold reduced hydroxymethylation levels (5hmC) in Tet1 KD mESCs (96h). Bottom: Log-fold enrich-
ment at down- versus up-regulated genes, respectively. (C) Expression fold changes of 919 genes differentially expressed upon Tet1 KD (96h; ﬁrst
column) presented alongside fold changes observed after KD or knockout (KO) of select other pluripotency factors in published reports. Genes are
represented along the y-axis. Data sets along the x-axis have been ordered based on unsupervised hierarchical clustering of corresponding gene
expression fold changes. Blue and yellow rectangles highlight Tet1-LIF and Polycomb clusters, respectively. Cells with no/missing data are colored in
gray (DKO: double KO).
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Figure 3. Dependence of LIF/Stat3 signaling on Tet1. (A) Two-dimensional gene density heatmap depicting global gene expression changes 96h
after Tet1 KD against changes observed 48h after LIF withdrawal (51). The intensity of each square represents the number of genes that fall within
that square. Axes indicate degree of fold change, from nil (middle of axis) to >1.5-fold (outermost squares). (B) Gene expression fold changes
observed in microarray analysis 48 and 96h after Tet1 KD in mESCs, and 48h after LIF withdrawal (51). (C) Relative Stat3 mRNA level in control
and Tet1 KD mESCs. The mRNA level in control KD cells is set as one. Data are normalized to Actin. Error bars represent SEM of three
experiments. (D) Western blot analysis showing protein levels in control and Tet1 KD (48h) mESCs. Tubulin is used as a loading control. (E) Left:
ChIP assay of select Stat3 target regions using an antibody against Stat3 in control KD and Tet1 KD mESCs (48h). The y-axis represents
enrichment over input normalized to a negative control region (Yipf2). Refer to Supplementary Figure S4 for data from control ChIP using a
non-speciﬁc antibody against IgG. Error bars represent SEM of three experiments. Right: Gene expression fold changes observed in microarray
analysis 48 and 96h after Tet1 KD in mESCs, and 48h after LIF withdrawal (51).
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Figure 4. Nanog overexpression or suppression of MAPK/ERK signaling rescues Tet1 KD phenotype. (A) Western blot analysis showing Nanog
overexpression with HA-tag. (B) AP staining of E14Tg2a mESCs, with and without Nanog overexpression, transfected with control siRNA and Tet1
siRNA #1. Cells were cultured in normal ESC medium, and AP staining was performed 96h after transfection. (C) Relative mRNA levels of selected
mESC pluripotency genes and differentiation marker genes in control and Tet1 KD mESCs in 2i medium. Oct4GiP cells were transfected with
control siRNA or Tet1 siRNA #1 at 50nM in 24-well plates in 2i-medium (which inhibits MAPK/ERK and Gsk-3b signaling) and cells were
harvested 96h after transfection. The mRNA levels in control cells are set as one. Data are normalized to Actin. Error bars represent SEM of three
experiments.
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Figure 5. Tet1 negatively regulates de novo DNA methyltransferase Dnmt3b.( A) ChIP assay of select Stat3 target regions using an antibody against
H3K9me3 in control and Tet1 KD mESCs (48h). The y-axis represents enrichment over input normalized to a positive control region (Myod1) for
H3K9me3. Error bars represent SEM of three experiments. (B) Relative mRNA levels of DNA methyltransferases Dnmt1, Dnmt3a and Dnmt3b in
control and Tet1 KD mESCs 96h after transfection. The mRNA levels in control cells are set as 1. Data are normalized to Actin. Error bars
represent SEM of three experiments. (C) Western blot analysis showing protein levels of Nanog, Dnmt3a and Dnmt3b in control and Tet1 KD
mESCs 96h after transfection. Ran is used as a loading control. (D) Genome browser shot showing a region containing the Dnmt3b gene and results
from Tet1 and Sin3a ChIP-Seq experiments by various groups (GSM numbers denote GEO accession). The red open rectangle highlights Tet1
occupancy at the promoter region of Dnmt3b, where a CpG island is present (green-ﬁlled rectangle). (E) Relative 5hmC levels at Dnmt3b locus in
control and Tet1 KD (96h) mESCs. Error bars represent SEM of three experiments.
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Given that genes downregulated in Tet1 KD cells undergo
a minor-to-moderate increase in 5mC levels (26–28,31),
and that repressive histone mark H3K9me3 has been
known to recruit DNA methyltransferases and be asso-
ciated with DNA methylation (35,60), we hypothesized
that the loss of Stat3 binding and Stat3-mediated activa-
tion of its targets accompanies an increase in H3K9me3.
ChIP using an antibody against H3K9me3 revealed that
this was indeed the case (Figure 5A). It is not clear,
however, whether Tet proteins alleviate/prevent gene
silencing at Stat3 targets by preventing deposition of
H3K9me3, or by maintaining a DNA-hypomethylated
state. Interestingly, we noticed a 2-fold increase in
Dnmt3b levels in Tet1 KD cells in microarray analysis
(Figure 1D). Quantitative RT-PCR and western blot con-
ﬁrmed the increase in Dnmt3b at the mRNA and protein
levels (Figure 5B and C). Since Tet1 targets Dnmt3b
(Figure 5D), we examined the 5hmC levels at the
Dnmt3b locus and found >3-fold reduction in 5hmC in
Tet1 KD cells (Figure 5E). Based on this evidence, it is
possible that Tet1’s regulation of DNA methylation might
also involve its negative regulation, direct or indirect, of de
novo DNA methyltransferase Dnmt3b.
DISCUSSION
Our studies indicate that acute short-term depletion as
opposed to long-term genetic deletion of Tet1 in mESCs
results in the loss of the mESC identity. Tet1 depletion, in
our hands, reduced total 5hmC levels by roughly 2- to
3-fold, Nanog expression by  3-fold and Tet2 expression
by  1.5-fold. The extent of 5hmC reduction positively
correlated with morphological changes and extent of loss
of AP staining (Figure 1) suggesting that it is the loss of
5hmC and not necessarily Tet1 that caused differentiation.
Our ﬁndings are consistent with those by another group
that used shRNAs to deplete Tet1 and observed similar
changes in morphology, global gene expression, Nanog,
Tet2 and total 5hmC levels (16,30). Our ﬁndings,
however, are in contrast to Tet1 depletion studies by
others (26–28,31), who observed only  1.5-fold reduction
in total 5hmC levels, no reduction in Nanog or Tet2 levels
and no distinguishable morphological changes. Most re-
markably, our results were reproducible even when using a
siRNA that was employed in two previous studies that
observed no obvious phenotype (28,31). Interestingly,
the molecular changes we observe after Tet1 depletion
are consistent with those from siRNA-mediated KD but
not shRNA-mediated KD with puromycin selection from
a previous study (31) (data from Xu et al in Figure 1D).
It should be noted that the only other study that reported
a Tet1 KD phenotype used shRNA-mediated depletion of
Tet1 with no antibiotic selection. Since the siRNAs we
used do not lead to greater KD efﬁciency than the
shRNAs used by studies with no phenotype, it is
possible that the lack of phenotype observed by others
could be the result of homeostatic compensation of
Tet1’s function masked by antibiotic selection.
At present, although we have no ready explanation for
the discrepancy between our results and those from Tet1
null mice (34), a modest reduction in 5hmC levels in the
genetic model raises an intriguing possibility of maternal
contribution or unaltered Tet2 expression compensating
for Tet1’s function after prolonged loss of Tet1, there-
fore masking the direct effect of Tet1 loss that we
observe hours/days after RNAi-mediated acute Tet1 KD.
Our ﬁndings suggest that an acute as opposed to long-term
chronic reduction in Tet1 and thus 5hmC levels is probably
difﬁcult for mESCs to overcome or compensate, thereby
resulting in the loss of the pluripotent state. This is
consistent with Tet2’s critical role in regulating
self-renewal, proliferation, and differentiation in hemato-
poietic stem cells (61–63), and Tet3’s requirement for
paternal genome conversion of 5mC into 5hmC (64–66).
The sharp reduction in Tet1 and 5hmC impaired
LIF-dependent Stat3-mediated gene activation by affecting
Stat3’s ability to bind to its target sites on chromatin,
indicating dependence of LIF/Stat3 signaling on
Tet1 and/or 5hmC. Suppression of prodifferentiative
Figure 6. Proposed model for Tet1-mediated epigenetic and transcriptional regulation of mESC self-renewal and pluripotency. Red arrows denote
regulatory interactions inferred from data generated for this study. Tet1, regulated by Oct4 (28), regulates DNA methylation (5mC) by converting
5mC to 5hmC (16,28). Tet1 regulates LIF/Stat3 signaling by facilitating Stat3 binding by an yet to be determined mechanism, and regulates the
transcriptional regulatory module comprising Nanog, Esrrb, Tcl1, Tbx3, Klf2/4, Prdm14 and Lefty1/2. Tet1’s regulation of Tet2 confers tight
regulation of 5mC to 5hmC conversion. Tet1’s negative regulation of de novo DNA methyltransferase Dnmt3b may provide an additional layer
of Tet1-mediated regulation of 5mC. Silent and active promoters on the chromatin are denoted by broad red and green arrows, respectively.
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to maintain mESCs in the absence of LIF or Stat3 activa-
tion, rescued Tet1 KD phenotype further supporting the
dependence of LIF/Stat3 signaling on Tet1. Collectively,
our results support a model in which the Tet1-mediated
regulation of 5hmC levels is critical to the maintenance
of the pluripotent state in mESCs (Figure 6). Tet1 aids
LIF-mediated Stat3 gene activation by facilitating Stat3
binding to chromatin by a yet to be determined mechan-
ism. Tet1 regulates key pluripotency-associated factors
including Nanog, Klf2/4, Tcl1, Tbx3, Esrrb, Lefty1/2,
Prdm14 and Tcfcp2l1. Regulation of DNA methylation
by Tet1-mediated conversion of 5mC to 5hmC also
involves Tet1’s regulation of Tet2 and Dnmt3b.O u r
ﬁndings suggest that studying mESCs in the hours/days
following depletion of Tet1, before any compensatory al-
terations could take place, reveals Tet1’s normal physio-
logical role in maintaining the pluripotent state, which may
be subject to homeostatic compensation in genetic models.
Tet1/2 double knockout may shed light into whether Tet2
is in fact compensating for Tet1’s loss in Tet1 null cells.
Further investigations are needed to better understand the
mechanistic role of Tet1 and 5hmC in facilitating
pluripotency, and LIF/Stat3 signaling.
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